Brain tumor ‘monorail’ lands FDA breakthrough device nod

(Photo by Heather Maguire on Unsplash)

A “tumor monorail” that lures aggressive brain tumor cells to their death in an external container has won “breakthrough device” designation from FDA.

The purpose of the device is not to destroy the glioblastoma tumor, but to halt its lethal spread, making the disease more of a condition to manage than a death sentence, according to researchers at Duke University’s Pratt School of Engineering.

Get the full story on our sister site, Medical Design & Outsourcing.

The post Brain tumor ‘monorail’ lands FDA breakthrough device nod appeared first on MassDevice.

from MassDevice http://bit.ly/2I8Xwig